See more : Encho Co.,Ltd. (8208.T) Income Statement Analysis – Financial Results
Complete financial analysis of Indigenous Bloom Hemp Corp. (VRTHF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Indigenous Bloom Hemp Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- ViaGold Rare Earth Resources Holdings Limited (VIA.AX) Income Statement Analysis – Financial Results
- Shenzhen Ecobeauty Co., Ltd. (000010.SZ) Income Statement Analysis – Financial Results
- Hung Hing Printing Group Limited (0450.HK) Income Statement Analysis – Financial Results
- Salzgitter AG (SZGPF) Income Statement Analysis – Financial Results
- Eagle Point Credit Company Inc. (ECCF) Income Statement Analysis – Financial Results
Indigenous Bloom Hemp Corp. (VRTHF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
About Indigenous Bloom Hemp Corp.
Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. The company is headquartered in Kelowna, Canada.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 176.48K | 244.70 | 383.77 | 10.48K | 14.50K | 1.04K | 0.00 | 0.00 |
Gross Profit | -176.48K | -244.70 | -383.77 | -10.48K | -14.50K | -1.04K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 148.81K | 75.17K | 32.91K | 0.00 | 0.00 |
General & Administrative | 334.68K | 690.03K | 2.42M | 4.14M | 12.98M | 3.30M | 864.11K | 231.21K |
Selling & Marketing | 0.00 | -129.12K | -645.14K | 84.95K | 154.15K | 77.69K | -174.26K | 0.00 |
SG&A | 334.68K | 560.91K | 1.78M | 4.29M | 10.12M | 2.42M | 689.86K | 231.21K |
Other Expenses | 123.76K | 86.14K | 0.00 | 14.45K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 461.51K | 560.91K | 1.78M | 4.44M | 10.20M | 2.45M | 689.86K | 231.21K |
Cost & Expenses | 637.99K | 560.91K | 1.78M | 4.45M | 10.21M | 2.45M | 689.86K | 231.21K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 8.38K | 14.49K | 0.00 | 0.00 | 0.00 | 24.53K | 39.59K | 0.00 |
Depreciation & Amortization | 109.22K | 83.82 | 50.80 | 10.48K | 14.50K | 1.04K | 22.82K | 289.00 |
EBITDA | -430.59K | -587.79K | -1.78M | -11.88M | -10.91M | -2.13M | -689.85K | -211.52K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -652.47K | -560.91K | -1.78M | -4.45M | -10.21M | -2.45M | -689.85K | -231.21K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -1.64M | -41.37K | -16.27K | -7.44M | -708.04K | 293.39K | -39.60K | -25.00K |
Income Before Tax | -2.29M | -602.28K | -1.80M | -11.89M | -10.92M | -2.16M | -729.45K | -256.21K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -480.48K | -82.59 | -50.80 | -5.00 | -108.13K | -13.17K | 107.33K | 472.29K |
Net Income | -2.29M | -602.28K | -1.80M | -11.89M | -10.81M | -2.14M | -836.78K | -728.79K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.03 | -0.07 | -0.29 | -2.63 | -4.61 | -1.51 | -0.82 | -0.76 |
EPS Diluted | -0.03 | -0.07 | -0.29 | -2.63 | -4.61 | -1.51 | -0.82 | -0.76 |
Weighted Avg Shares Out | 68.30K | 8.18M | 6.19M | 4.51M | 2.35M | 1.42M | 1.02M | 961.99K |
Weighted Avg Shares Out (Dil) | 68.30K | 8.18M | 6.19M | 4.51M | 2.35M | 1.42M | 1.02M | 961.99K |
Source: https://incomestatements.info
Category: Stock Reports